Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Synthetic Biologics, Inc. (SYN) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

Synthetic Biologics is a biotechnology company focused on the development of product candidates for serious infections and diseases, such as for the prevention of C. difficile infection. SYN is also developing a drug candidate for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS, and is designing a clinical development pathway for the treatment of amyotrophic lateral sclerosis. For more information, visit the company’s Web site: http://www.syntheticbiologics.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *